Medicine for Osteoarthritis Pain Market Report

Global and Region Medicine for Osteoarthritis Pain Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：233
  • REPORT CODE：GMM996501
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Medicine for Osteoarthritis Pain market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Medicine for Osteoarthritis Painmarket, defines the market attractiveness level of Medicine for Osteoarthritis Pain market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Medicine for Osteoarthritis Pain industry, describes the types of Medicine for Osteoarthritis Pain market, the applications of major players and the market size, and deeply analyzes the current situation of the global Medicine for Osteoarthritis Pain market and the development prospects and opportunities of Medicine for Osteoarthritis Pain industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Medicine for Osteoarthritis Pain market in Chapter 13.

    By Player:

    • Novartis

    • Abiogen Pharma

    • Sanofi

    • Eli Lilly

    • Tide Pharmaceutical

    • TEVA

    • Iroko Pharmaceuticals

    • Pfizer

    • Hengrui Pharmaceutical

    • Mylan

    • Horizon Pharma

    • Johnson & Johnson

    • Astellas Pharma

    • Bayer

    • Almatica Pharma

    • GlaxoSmithKline

    • Abbott

    • Daiichi Sankyo

    By Type:

    • Oral

    • Injection

    • External

    By End-User:

    • Medical Care

    • Personal Care

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Medicine for Osteoarthritis Pain Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Medicine for Osteoarthritis Pain Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Medicine for Osteoarthritis Pain Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Medicine for Osteoarthritis Pain Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Medicine for Osteoarthritis Pain Market Analysis and Outlook to 2022

    • 7.1 Global Medicine for Osteoarthritis Pain Consumption (2017-2022)

    • 7.2 United States Medicine for Osteoarthritis Pain Consumption (2017-2022)

    • 7.3 Europe Medicine for Osteoarthritis Pain Consumption (2017-2022)

    • 7.4 China Medicine for Osteoarthritis Pain Consumption (2017-2022)

    • 7.5 Japan Medicine for Osteoarthritis Pain Consumption (2017-2022)

    • 7.6 India Medicine for Osteoarthritis Pain Consumption (2017-2022)

    • 7.7 South Korea Medicine for Osteoarthritis Pain Consumption (2017-2022)

    8 Region and Country-wise Medicine for Osteoarthritis Pain Market Analysis and Outlook to 2028

    • 8.1 Global Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)

    • 8.2 United States Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)

    • 8.3 Europe Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)

    • 8.4 China Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)

    • 8.5 Japan Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)

    • 8.6 India Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)

    • 8.7 South Korea Medicine for Osteoarthritis Pain Consumption Forecast (2022-2028)

    9 Global Medicine for Osteoarthritis Pain Market Outlook by Types and Applications to 2022

    • 9.1 Global Medicine for Osteoarthritis Pain Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oral Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Injection Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global External Consumption and Growth Rate (2017-2022)

    • 9.2 Global Medicine for Osteoarthritis Pain Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Medical Care Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Personal Care Consumption and Growth Rate (2017-2022)

    10 Global Medicine for Osteoarthritis Pain Market Outlook by Types and Applications to 2028

    • 10.1 Global Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Injection Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global External Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Medical Care Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Personal Care Consumption Forecast and Growth Rate (2022-2028)

    11 Global Medicine for Osteoarthritis Pain Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Medicine for Osteoarthritis Pain Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Medicine for Osteoarthritis Pain Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Medicine for Osteoarthritis Pain Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Medicine for Osteoarthritis Pain Market Competitive Analysis

    • 14.1 Novartis

      • 14.1.1 Novartis Company Details

      • 14.1.2 Novartis Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Novartis Medicine for Osteoarthritis Pain Product and Service

    • 14.2 Abiogen Pharma

      • 14.2.1 Abiogen Pharma Company Details

      • 14.2.2 Abiogen Pharma Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Abiogen Pharma Medicine for Osteoarthritis Pain Product and Service

    • 14.3 Sanofi

      • 14.3.1 Sanofi Company Details

      • 14.3.2 Sanofi Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Sanofi Medicine for Osteoarthritis Pain Product and Service

    • 14.4 Eli Lilly

      • 14.4.1 Eli Lilly Company Details

      • 14.4.2 Eli Lilly Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Eli Lilly Medicine for Osteoarthritis Pain Product and Service

    • 14.5 Tide Pharmaceutical

      • 14.5.1 Tide Pharmaceutical Company Details

      • 14.5.2 Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Tide Pharmaceutical Medicine for Osteoarthritis Pain Product and Service

    • 14.6 TEVA

      • 14.6.1 TEVA Company Details

      • 14.6.2 TEVA Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 TEVA Medicine for Osteoarthritis Pain Product and Service

    • 14.7 Iroko Pharmaceuticals

      • 14.7.1 Iroko Pharmaceuticals Company Details

      • 14.7.2 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Product and Service

    • 14.8 Pfizer

      • 14.8.1 Pfizer Company Details

      • 14.8.2 Pfizer Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Pfizer Medicine for Osteoarthritis Pain Product and Service

    • 14.9 Hengrui Pharmaceutical

      • 14.9.1 Hengrui Pharmaceutical Company Details

      • 14.9.2 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Product and Service

    • 14.10 Mylan

      • 14.10.1 Mylan Company Details

      • 14.10.2 Mylan Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Mylan Medicine for Osteoarthritis Pain Product and Service

    • 14.11 Horizon Pharma

      • 14.11.1 Horizon Pharma Company Details

      • 14.11.2 Horizon Pharma Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Horizon Pharma Medicine for Osteoarthritis Pain Product and Service

    • 14.12 Johnson & Johnson

      • 14.12.1 Johnson & Johnson Company Details

      • 14.12.2 Johnson & Johnson Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Johnson & Johnson Medicine for Osteoarthritis Pain Product and Service

    • 14.13 Astellas Pharma

      • 14.13.1 Astellas Pharma Company Details

      • 14.13.2 Astellas Pharma Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Astellas Pharma Medicine for Osteoarthritis Pain Product and Service

    • 14.14 Bayer

      • 14.14.1 Bayer Company Details

      • 14.14.2 Bayer Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Bayer Medicine for Osteoarthritis Pain Product and Service

    • 14.15 Almatica Pharma

      • 14.15.1 Almatica Pharma Company Details

      • 14.15.2 Almatica Pharma Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Almatica Pharma Medicine for Osteoarthritis Pain Product and Service

    • 14.16 GlaxoSmithKline

      • 14.16.1 GlaxoSmithKline Company Details

      • 14.16.2 GlaxoSmithKline Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 GlaxoSmithKline Medicine for Osteoarthritis Pain Product and Service

    • 14.17 Abbott

      • 14.17.1 Abbott Company Details

      • 14.17.2 Abbott Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Abbott Medicine for Osteoarthritis Pain Product and Service

    • 14.18 Daiichi Sankyo

      • 14.18.1 Daiichi Sankyo Company Details

      • 14.18.2 Daiichi Sankyo Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Daiichi Sankyo Medicine for Osteoarthritis Pain Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Medicine for Osteoarthritis Pain

    • Figure Medicine for Osteoarthritis Pain Picture

    • Table Global Medicine for Osteoarthritis Pain Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Medicine for Osteoarthritis Pain Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Medicine for Osteoarthritis Pain Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Medicine for Osteoarthritis Pain Consumption by Country (2017-2022)

    • Figure United States Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Table Europe Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure China Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Japan Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure India Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure South Korea Medicine for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)

    • Figure Global Medicine for Osteoarthritis Pain Consumption Forecast by Country (2022-2028)

    • Figure United States Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Medicine for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Consumption and Growth Rate (2017-2022)

    • Figure Global Injection Consumption and Growth Rate (2017-2022)

    • Figure Global External Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Care Consumption and Growth Rate (2017-2022)

    • Figure Global Personal Care Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global External Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Care Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Personal Care Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Medicine for Osteoarthritis Pain Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Medicine for Osteoarthritis Pain Export by Region (Top 5 Countries) (2017-2028)

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Medicine for Osteoarthritis Pain Product and Service

    • Table Abiogen Pharma (Foundation Year, Company Profile and etc.)

    • Table Abiogen Pharma Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abiogen Pharma Medicine for Osteoarthritis Pain Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Medicine for Osteoarthritis Pain Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Medicine for Osteoarthritis Pain Product and Service

    • Table Tide Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tide Pharmaceutical Medicine for Osteoarthritis Pain Product and Service

    • Table TEVA (Foundation Year, Company Profile and etc.)

    • Table TEVA Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table TEVA Medicine for Osteoarthritis Pain Product and Service

    • Table Iroko Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Medicine for Osteoarthritis Pain Product and Service

    • Table Hengrui Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Medicine for Osteoarthritis Pain Product and Service

    • Table Horizon Pharma (Foundation Year, Company Profile and etc.)

    • Table Horizon Pharma Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Horizon Pharma Medicine for Osteoarthritis Pain Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Medicine for Osteoarthritis Pain Product and Service

    • Table Astellas Pharma (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Medicine for Osteoarthritis Pain Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Medicine for Osteoarthritis Pain Product and Service

    • Table Almatica Pharma (Foundation Year, Company Profile and etc.)

    • Table Almatica Pharma Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Almatica Pharma Medicine for Osteoarthritis Pain Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Medicine for Osteoarthritis Pain Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Medicine for Osteoarthritis Pain Product and Service

    • Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo Medicine for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Medicine for Osteoarthritis Pain Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US